/PEG.CO
PEG.CO Stock - Pharma Equity Group A/S
Healthcare|BiotechnologyCPH
$0.09+0.21%
+$0.00 (+0.21%) • Dec 23
53
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.9
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.82
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PEG.CO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.09 – $0.09
TARGET (TP)$0.11
STOP LOSS$0.09
RISK/REWARD1:4.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.94
52W High$0.19
52W Low$0.07
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-235,000 | $-480,000 | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-21,287,000 | $-25,293,000 | $3.03M | $-1,444,000 | $-17,611,000 |
| Net Income | $-24,422,000 | $-24,609,000 | $3.48M | $5.39M | $-32,875,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.02 | $-0.02 | $0.09 | $0.10 | $-1.03 |
Company Overview
Pharma Equity Group A/S invests in companies with a primary focus on life sciences. It focuses on early investment in life science companies that develop technologies and therapies that enhances human health and quality of life. The company is based in Hørsholm, Denmark.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PEG.COBeat Rate
0%
Last 2 quarters
Avg Surprise
+0.0%
EPS vs Estimate
Beats / Misses
0/0
2 met exactly
Latest EPS
$-0.01
Q2 2025
EPS Surprise History
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
0.0%
$-0.01vs$-0.01
Q1 25
No data
Q2 25
0.0%
$-0.01vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 14, 2025 | — | — | — | — |
Q2 2025 | May 15, 2025 | $-0.01 | $-0.01 | 0.0% | = MET |
Q1 2025 | Mar 20, 2025 | — | $-0.02 | — | — |
Q4 2024 | Nov 15, 2024 | $-0.01 | $-0.01 | 0.0% | = MET |
Q3 2024 | Aug 16, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 26, 2024 | — | $-0.01 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.01 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.14 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.01 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.01 | — | — |
Q1 2016 | Mar 31, 2016 | — | $-0.02 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.03 | — | — |
Q3 2015 | Sep 30, 2015 | — | $-0.04 | — | — |
Q2 2015 | Jun 30, 2015 | — | $-0.20 | — | — |
Q1 2015 | Mar 31, 2015 | — | $-0.15 | — | — |
Q4 2014 | Dec 31, 2014 | — | $-0.75 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PEG.CO
What is PEG.CO's current stock price?
Pharma Equity Group A/S (PEG.CO) is currently trading at $0.09 per share. The stock has moved +0.21% today.
What is the analyst price target for PEG.CO?
No analyst price targets are currently available for this stock.
What sector is Pharma Equity Group A/S in?
Pharma Equity Group A/S operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the CPH exchange.
What is PEG.CO's market cap?
Pharma Equity Group A/S has a market capitalization of $0.11 billion, making it a small-cap company.
Does PEG.CO pay dividends?
No, Pharma Equity Group A/S does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBRAINP.CO
Brain+ A/S
$0.01
Mkt Cap: $0.0B
MONSO.CO
Monsenso A/S
$0.16
Mkt Cap: $0.0B
SMSMED.CO
Scandinavian Medical Solutions A/S
$4.75
Mkt Cap: $0.1B
STENO.CO
Stenocare A/S
$1.47
Mkt Cap: $0.1B
VIRO.CO
ViroGates A/S
$12.05
Mkt Cap: $0.1B
Explore stocks similar to PEG.CO for comparison